DOJ reported that a Louisiana nurse practitioner was sentenced to 87 months for causing more than $12 million in alleged false and fraudulent Medicare claims. Prosecutors said the claims stemmed from medically unnecessary cancer genetic tests and involved kickbacks and misleading statements about medical necessity.

The U.S. Department of Justice announced a major health-care fraud sentencing: a Louisiana nurse practitioner received an 87-month prison term tied to alleged $12 million in false and fraudulent Medicare claims. DOJ alleged the scheme involved medically unnecessary cancer genetic tests submitted to Medicare, along with kickback arrangements that, according to the government, were used to induce referrals. In DOJ’s description, the conduct included misleading representations regarding Medicare standards and the medical necessity of the testing. Prosecutors’ focus on “medical necessity” deception reflects a recurring fraud mechanism in health-care scams: even when services are billed, the provider may allegedly mischaracterize whether the services meet payer criteria, turning questionable testing into billable claims. Kickbacks add a second layer to the alleged fraud. By rewarding referrals or generating testing volume through improper payments, kickback schemes can create incentives to order tests that are not clinically justified. DOJ’s sentencing underscores that regulators and prosecutors treat these arrangements as criminal, not merely billing violations. For consumers and health-care patients, the case reinforces a key warning: payers and prosecutors may investigate not only who ordered the tests, but whether the medical reasoning supporting billing was legitimate. It also highlights that health-care fraud enforcement can target both clinical documentation and underlying referral-compensation structures.